Heideman DA - Search Results

1

Bronchioloalveolar adenocarcinoma and pulmonary langerhans cell histiocytosis in a patient with MUTYH-associated polyposis.

von der Thüsen JH, van de Wetering MD, Westermann AM, Heideman DA, Thunnissen E. von der Thüsen JH, et al. Among authors: heideman da. J Clin Oncol. 2011 Mar 10;29(8):e188-90. doi: 10.1200/JCO.2010.32.1026. Epub 2010 Dec 28. J Clin Oncol. 2011. PMID: 21189386 No abstract available.

2

Dramatic response to low-dose erlotinib of epidermal growth factor receptor mutation-positive recurrent non-small cell lung cancer after severe cutaneous toxicity.

Lind JS, Postmus PE, Heideman DA, Thunnissen EB, Bekers O, Smit EF. Lind JS, et al. Among authors: heideman da. J Thorac Oncol. 2009 Dec;4(12):1585-6. doi: 10.1097/JTO.0b013e3181bbb2b9. J Thorac Oncol. 2009. PMID: 20009914 Free article.

3

A multicenter phase II study of erlotinib and sorafenib in chemotherapy-naive patients with advanced non-small cell lung cancer.

Lind JS, Dingemans AM, Groen HJ, Thunnissen FB, Bekers O, Heideman DA, Honeywell RJ, Giovannetti E, Peters GJ, Postmus PE, van Suylen RJ, Smit EF. Lind JS, et al. Among authors: heideman da. Clin Cancer Res. 2010 Jun 1;16(11):3078-87. doi: 10.1158/1078-0432.CCR-09-3033. Epub 2010 Apr 15. Clin Cancer Res. 2010. PMID: 20395213 Free article. Clinical Trial.

4

EGFR and KRAS quality assurance schemes in pathology: generating normative data for molecular predictive marker analysis in targeted therapy.

Thunnissen E, Bovée JV, Bruinsma H, van den Brule AJ, Dinjens W, Heideman DA, Meulemans E, Nederlof P, van Noesel C, Prinsen CF, Scheidel K, van de Ven PM, de Weger R, Schuuring E, Ligtenberg M. Thunnissen E, et al. Among authors: heideman da. J Clin Pathol. 2011 Oct;64(10):884-92. doi: 10.1136/jclinpath-2011-200163. J Clin Pathol. 2011. PMID: 21947301

5

KRAS and BRAF mutation analysis in routine molecular diagnostics: comparison of three testing methods on formalin-fixed, paraffin-embedded tumor-derived DNA.

Heideman DA, Lurkin I, Doeleman M, Smit EF, Verheul HM, Meijer GA, Snijders PJ, Thunnissen E, Zwarthoff EC. Heideman DA, et al. J Mol Diagn. 2012 May-Jun;14(3):247-55. doi: 10.1016/j.jmoldx.2012.01.011. Epub 2012 Mar 14. J Mol Diagn. 2012. PMID: 22425762 Free article.

6

Prolonged sampling of spontaneous sputum improves sensitivity of hypermethylation analysis for lung cancer.

Hubers AJ, Heideman DA, Herder GJ, Burgers SA, Sterk PJ, Kunst PW, Smit HJ, Postmus PE, Witte BI, Duin S, Snijders PJ, Smit EF, Thunnissen E. Hubers AJ, et al. Among authors: heideman da. J Clin Pathol. 2012 Jun;65(6):541-5. doi: 10.1136/jclinpath-2012-200712. Epub 2012 Mar 29. J Clin Pathol. 2012. PMID: 22461647

7

Negative NKX2-1 (TTF-1) as temporary surrogate marker for treatment selection during EGFR-mutation analysis in patients with non-small-cell lung cancer.

Vincenten J, Smit EF, Vos W, Grünberg K, Postmus PE, Heideman DA, Snijders PJ, Meijer G, Kuik J, Witte BI, Thunnissen E. Vincenten J, et al. Among authors: heideman da. J Thorac Oncol. 2012 Oct;7(10):1522-7. doi: 10.1097/JTO.0b013e3182635a91. J Thorac Oncol. 2012. PMID: 22982653 Free article.

8

Correlation of immunohistochemical staining p63 and TTF-1 with EGFR and K-ras mutational spectrum and diagnostic reproducibility in non small cell lung carcinoma.

Thunnissen E, Boers E, Heideman DA, Grünberg K, Kuik DJ, Noorduin A, van Oosterhout M, Pronk D, Seldenrijk C, Sietsma H, Smit EF, van Suylen R, von der Thusen J, Vrugt B, Wiersma A, Witte BI, den Bakker M. Thunnissen E, et al. Among authors: heideman da. Virchows Arch. 2012 Dec;461(6):629-38. doi: 10.1007/s00428-012-1324-x. Epub 2012 Oct 12. Virchows Arch. 2012. PMID: 23064619

9

A patient with simultaneously appearing adenocarcinoma and small-cell lung carcinoma harbouring an identical EGFR exon 19 mutation.

van Riel S, Thunnissen E, Heideman D, Smit EF, Biesma B. van Riel S, et al. Ann Oncol. 2012 Dec;23(12):3188-3189. doi: 10.1093/annonc/mds525. Epub 2012 Oct 18. Ann Oncol. 2012. PMID: 23079729 Free article. No abstract available.

10

Development of [(11)C]erlotinib positron emission tomography for in vivo evaluation of EGF receptor mutational status.

Bahce I, Smit EF, Lubberink M, van der Veldt AA, Yaqub M, Windhorst AD, Schuit RC, Thunnissen E, Heideman DA, Postmus PE, Lammertsma AA, Hendrikse NH. Bahce I, et al. Among authors: heideman da. Clin Cancer Res. 2013 Jan 1;19(1):183-93. doi: 10.1158/1078-0432.CCR-12-0289. Epub 2012 Nov 7. Clin Cancer Res. 2013. PMID: 23136193

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

229 results

Search Page

Filters